Insider Buying: Cerecor Inc (CERC) Director Acquires 5,000 Shares of Stock

Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc acquired 5,000 shares of the stock in a transaction that occurred on Friday, November 23rd. The shares were bought at an average price of $3.64 per share, for a total transaction of $18,200.00. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.

Armistice Capital, Llc also recently made the following trade(s):

  • On Monday, November 26th, Armistice Capital, Llc acquired 35,000 shares of Cerecor stock. The shares were bought at an average price of $3.58 per share, for a total transaction of $125,300.00.
  • On Wednesday, November 21st, Armistice Capital, Llc acquired 10,000 shares of Cerecor stock. The shares were bought at an average price of $3.58 per share, for a total transaction of $35,800.00.
  • On Monday, November 19th, Armistice Capital, Llc acquired 23,800 shares of Cerecor stock. The shares were bought at an average price of $3.56 per share, for a total transaction of $84,728.00.
  • On Thursday, November 15th, Armistice Capital, Llc acquired 11,218 shares of Cerecor stock. The shares were bought at an average price of $3.80 per share, for a total transaction of $42,628.40.
  • On Tuesday, November 13th, Armistice Capital, Llc acquired 15,287 shares of Cerecor stock. The shares were bought at an average price of $3.90 per share, for a total transaction of $59,619.30.
  • On Wednesday, October 31st, Armistice Capital, Llc acquired 4,586 shares of Cerecor stock. The shares were bought at an average price of $3.91 per share, for a total transaction of $17,931.26.
  • On Monday, October 29th, Armistice Capital, Llc acquired 33,292 shares of Cerecor stock. The shares were bought at an average price of $3.94 per share, for a total transaction of $131,170.48.
  • On Friday, October 26th, Armistice Capital, Llc acquired 55,899 shares of Cerecor stock. The shares were bought at an average price of $3.94 per share, for a total transaction of $220,242.06.
  • On Wednesday, October 24th, Armistice Capital, Llc bought 83,800 shares of Cerecor stock. The shares were acquired at an average cost of $4.06 per share, with a total value of $340,228.00.
  • On Monday, October 22nd, Armistice Capital, Llc bought 20,000 shares of Cerecor stock. The shares were acquired at an average cost of $4.31 per share, with a total value of $86,200.00.

CERC stock traded up $0.04 during midday trading on Monday, reaching $3.56. 100,800 shares of the company’s stock traded hands, compared to its average volume of 164,871. Cerecor Inc has a 52-week low of $1.23 and a 52-week high of $5.74. The stock has a market cap of $143.64 million, a P/E ratio of 8.48 and a beta of 1.48. The company has a current ratio of 0.74, a quick ratio of 0.70 and a debt-to-equity ratio of 0.74.

A number of brokerages have commented on CERC. TheStreet raised shares of Cerecor from a “d” rating to a “c” rating in a report on Monday, November 12th. ValuEngine raised shares of Cerecor from a “hold” rating to a “buy” rating in a report on Thursday, November 1st.

A number of hedge funds have recently made changes to their positions in the business. Cambridge Investment Research Advisors Inc. bought a new position in shares of Cerecor during the 3rd quarter worth about $169,000. BlackRock Inc. boosted its position in shares of Cerecor by 630.4% during the 2nd quarter. BlackRock Inc. now owns 27,520 shares of the company’s stock worth $120,000 after purchasing an additional 23,752 shares in the last quarter. Finally, Spark Investment Management LLC bought a new position in shares of Cerecor during the 2nd quarter worth about $288,000. 41.66% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Insider Buying: Cerecor Inc (CERC) Director Acquires 5,000 Shares of Stock” was originally published by WKRB News and is the sole property of of WKRB News. If you are reading this news story on another publication, it was copied illegally and republished in violation of international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.wkrb13.com/2018/11/27/insider-buying-cerecor-inc-cerc-director-acquires-5000-shares-of-stock.html.

Cerecor Company Profile

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation.

Further Reading: What are defining characteristics of a correction?

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply